Harvard, MA, United States of America

Karl Henry Nocka

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Sloan-Kettering Institute for Cancer Research, Cytomed, Inc., Pfizer Corporation. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Henry Nocka. Retrieved from https://idiyas.com/inventor/karl-henry-nocka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 1996-2020

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Mind of Karl Henry Nocka

Introduction

Karl Henry Nocka, based in Harvard, MA, is a prominent inventor holding a remarkable portfolio of eight patents. His contributions to the field of pharmaceuticals and immunology reflect a deep understanding of complex biological processes. His innovations focus on therapies and methodologies that have the potential to significantly enhance patient treatment options.

Latest Patents

One of Nocka's latest patents includes the development of Anti-IL-33 antibodies, which specifically bind to IL-33, a cytokine involved in various inflammatory processes. This invention also outlines associated methods and uses of these antibodies, demonstrating their potential therapeutic applications.

Another notable patent is the C-kit ligand-based method for expanding peripheral blood cell levels. This invention presents a pharmaceutical composition that combines the c-kit ligand (KL) with hematopoietic factors and a pharmaceutically acceptable carrier. The method aims to treat patients by administering this composition, and it also explores combination therapies using KL and other factors, further showcasing Nocka's innovative approach to treating blood cell disorders.

Career Highlights

Nocka has collaborated with esteemed institutions such as the Sloan-Kettering Institute for Cancer Research and Cytomed, Inc. His work in these organizations reflects his dedication to advancing medical science and improving therapeutic strategies.

Collaborations

Throughout his career, Nocka has worked closely with notable individuals, including Peter Besmer and Jochen Buck. These collaborations have surely enriched his research and inventive processes, allowing for a more comprehensive exploration of his innovative ideas.

Conclusion

Karl Henry Nocka's contributions to medical innovation have not only advanced scientific understanding but also opened new avenues for treatment options. His extensive patent portfolio illustrates his commitment to improving healthcare through cutting-edge inventions. Nocka's journey as an inventor continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…